Detalles de la búsqueda
1.
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
Br J Cancer
; 130(1): 73-81, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951974
2.
Population-based study of disease trajectory after radical treatment for high-risk prostate cancer.
BJU Int
; 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621388
3.
How does artificial intelligence master urological board examinations? A comparative analysis of different Large Language Models' accuracy and reliability in the 2022 In-Service Assessment of the European Board of Urology.
World J Urol
; 42(1): 20, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197996
4.
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study.
Future Oncol
; 20(10): 563-578, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126311
5.
Evaluating the Efficacy of AI Chatbots as Tutors in Urology: A Comparative Analysis of Responses to the 2022 In-Service Assessment of the European Board of Urology.
Urol Int
; 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555637
6.
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
World J Urol
; 41(12): 3535-3542, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966506
7.
A Rejected Hypothesis: Phenomenon of High Treatment Adherence in Direct-to-Consumer Teledermatology Despite Lack of Direct Physician-Patient Interaction.
Telemed J E Health
; 29(7): 1051-1056, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36480808
8.
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study.
Lancet Oncol
; 22(11): 1541-1559, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34600602
9.
Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis.
J Urol
; 205(4): 956-966, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284711
10.
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study.
J Urol
; 203(3): 496-504, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609167
11.
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Int J Clin Oncol
; 25(1): 145-150, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471787
12.
How to improve penile cancer management by enhanced centralisation - learning from the Dutch example.
BJU Int
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589342
13.
Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience.
Urol Int
; 103(3): 297-302, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31434090
14.
Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma.
Urol Int
; 101(4): 409-416, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30199877
15.
Radiographic progression-free survival in the ACIS trial for prostate cancer - Authors' reply.
Lancet Oncol
; 23(1): e5-e6, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973233
16.
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.
World J Urol
; 35(12): 1807-1816, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28702843
17.
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
World J Urol
; 35(2): 245-250, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27300339
18.
[Do General Surgeons Feel Adequately Prepared for the Complex Questions Associated with the Handling of Multi-Resistant Pathogens? - Results of the MR2 Survey]. / Fühlen sich Chirurgen gerüstet für die komplexen Fragestellungen im Umgang mit multiresistenten Erregern? Ergebnisse der Fragebogenstudie MR2.
Zentralbl Chir
; 142(3): 297-305, 2017 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-28641352
19.
20.
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
BJU Int
; 117(2): 272-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25381844